Skip to content
PubMed This is a summary of 62 peer-reviewed journal articles Updated
Neurology

Huntington disease-like 2: A Patient Guide

At a Glance

Huntington disease-like 2 (HDL2) is a rare inherited brain disorder linked to a JPH3 gene expansion. It can cause progressive movement, mood, and thinking changes that resemble Huntington disease; care focuses on symptom management and support because there is no cure.

Huntington disease-like 2 (HDL2) is a rare, inherited neurological condition that affects how the brain coordinates movement, regulates mood, and processes information [1]. Because its symptoms—such as involuntary movements, changes in personality, and shifts in thinking—closely mirror those of Huntington’s Disease (HD), it is considered a “phenocopy” or an HD-like condition [2]. For many families, the journey to this diagnosis begins when a standard test for Huntington’s comes back negative, necessitating a deeper look at the JPH3 gene, where the specific genetic expansion for HDL2 is found [3].

The biology of the condition has a historical context: researchers have reported a shared founder haplotype, meaning there is a strong association with African or Afro-descendant ancestry [4]. However, ancestry is an epidemiologic clue, not a rigid diagnostic requirement; testing should be guided by a person’s symptoms, family history, and specialist assessment rather than ancestry alone. Over time, the genetic mutation disrupts the health of brain cells, which can cause progressive changes in movement, thinking, and mood, with substantial variation between people [5].

While the physical symptoms often begin with subtle, “dance-like” twitching (chorea), the condition may eventually transition into a pattern of muscle stiffness and slower movement [6]. Alongside these physical changes, many people experience significant emotional shifts, such as depression, apathy, or irritability [7]. It is important to remember that mood symptoms can also be influenced by life circumstances, medication side effects, or sleep issues, and should be clinically assessed rather than automatically attributed only to the disease progression.

Because there is currently no cure, the focus of modern medical care is on managing symptoms and protecting your quality of life [8]. This is best achieved through a multidisciplinary team—including neurologists, psychiatrists, and therapists—who work together to tailor treatments to your specific needs [9]. While the rarity of HDL2 can feel isolating, you are not navigating this path alone; the established resources, advocacy networks, and support systems of the Huntington’s community provide a robust framework for care and connection, even as you manage a distinct condition [10]. Understanding the nature of the condition allows you and your family to plan for the future with clarity, focusing on the support systems that help you live well today.

Common questions in this guide

What is Huntington disease-like 2?
Huntington disease-like 2, or HDL2, is a rare inherited neurological condition caused by a specific genetic expansion in the JPH3 gene. It can affect movement, mood, personality, and thinking in ways that resemble Huntington disease.
Can I have HDL2 if my Huntington disease test is negative?
Yes. A standard Huntington disease test can be negative in someone whose symptoms and family history suggest another Huntington-like condition, including HDL2. A specialist may consider testing for the JPH3 expansion when the clinical picture supports it.
What symptoms can HDL2 cause?
HDL2 may cause involuntary, dance-like movements called chorea, along with changes in mood, personality, and thinking. As the condition progresses, some people develop muscle stiffness and slower movement, although symptoms vary substantially between individuals.
Does African or Afro-descendant ancestry mean that I have HDL2?
No. HDL2 has a strong reported association with African or Afro-descendant ancestry, but ancestry is an epidemiologic clue rather than a diagnostic requirement. Testing decisions should be based on symptoms, family history, and specialist assessment.
Is there a cure for Huntington disease-like 2?
There is currently no cure for HDL2. Care focuses on managing symptoms and protecting quality of life through a coordinated team that may include neurologists, psychiatrists, and therapists.
What support is available for people and families affected by HDL2?
Families may benefit from genetic counseling, mental health support, and coordinated care from a multidisciplinary medical team. Huntington disease advocacy networks and support communities can also offer education, connection, and practical resources while recognizing that HDL2 is a distinct condition.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Since my symptoms closely resemble Huntington's, how do we ensure we consider all relevant genetic possibilities, including JPH3, regardless of my ancestry?
  2. 2.Which specialist on my team will be the primary lead for coordinating my care across different disciplines?
  3. 3.How do you stay updated on the latest research and clinical trials for rare HD-like conditions?
  4. 4.Can you recommend a genetic counselor who has experience specifically with the family implications of HDL2?
  5. 5.What specific symptoms or changes should prompt me to call your office between our scheduled visits?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (10)
  1. 1

    Comparison of the Huntington's Disease like 2 and Huntington's Disease Clinical Phenotypes.

    Anderson DG, Ferreira-Correia A, Rodrigues FB, et al.

    Movement disorders clinical practice 2019; (6(4)):302-311 doi:10.1002/mdc3.12742.

    PMID: 31061838
  2. 2

    Huntington's disease-like 2 patients' profile in a Brazilian cohort.

    Boone DL, Tumas V, Vilela G, et al.

    Parkinsonism & related disorders 2025; (139()):108023 doi:10.1016/j.parkreldis.2025.108023.

    PMID: 40914005
  3. 3

    Junctophilin 3 (JPH3) expansion mutations causing Huntington disease like 2 (HDL2) are common in South African patients with African ancestry and a Huntington disease phenotype.

    Krause A, Mitchell C, Essop F, et al.

    American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2015; (168(7)):573-85 doi:10.1002/ajmg.b.32332.

    PMID: 26079385
  4. 4

    Spinocerebellar ataxia type 10 and Huntington disease-like 2 in Venezuela: Further evidence of two different ancestral founder effects.

    Paradisi I, Arias S, Ikonomu V

    Annals of human genetics 2024; (88(6)):445-454 doi:10.1111/ahg.12576.

    PMID: 39212267
  5. 5

    Huntington's disease-like 2 with an expansion mutation of the Junctophilin-3 gene; first reported case from Botswana.

    Ocampo C, Daimari R, Oyekunle AA

    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2018; (47()):126-127 doi:10.1016/j.jocn.2017.10.025.

    PMID: 29066237
  6. 6

    Atypical Presentations of Huntington Disease-like 2 in South African Individuals.

    Narotam-Jeena H, Guttman M, van Hillegondsberg L, et al.

    Movement disorders clinical practice 2024; (11(7)):850-854 doi:10.1002/mdc3.14052.

    PMID: 38725192
  7. 7

    The Neuropsychiatry of Huntington Disease-Like 2: A Comparison with Huntington's Disease.

    Ferreira-Correia A, Krause A, Anderson DG

    Journal of Huntington's disease 2020; (9(4)):325-334 doi:10.3233/JHD-200422.

    PMID: 33044188
  8. 8

    Current knowledge of Huntington's disease-like 2 genetic testing, clinical presentation, and patient experiences: A systematic review.

    Hoffmann K, White S, Sexton A

    Journal of Huntington's disease 2026; (15(3)):293-316 doi:10.1177/18796397251411109.

    PMID: 41564273
  9. 9

    What we don't need to prove but need to do in multidisciplinary treatment and care in Huntington's disease: a position paper.

    Mühlbӓck A, van Walsem M, Nance M, et al.

    Orphanet journal of rare diseases 2023; (18(1)):19 doi:10.1186/s13023-023-02622-8.

    PMID: 36717864
  10. 10

    Huntington's disease: diagnosis and management.

    Stoker TB, Mason SL, Greenland JC, et al.

    Practical neurology 2022; (22(1)):32-41 doi:10.1136/practneurol-2021-003074.

    PMID: 34413240

This page is for informational purposes only and does not constitute medical advice about Huntington disease-like 2. Discuss symptoms, genetic testing, and care decisions with your neurologist, genetic counselor, or other healthcare professional.

Get notified when new evidence is published on Huntington disease-like 2.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.